Altering protein specificity: techniques and applications

被引:48
作者
Antikainen, NM [1 ]
Martin, SF [1 ]
机构
[1] Univ Texas, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA
基金
美国国家卫生研究院;
关键词
protein engineering; enzyme specificity; mutagenesis;
D O I
10.1016/j.bmc.2005.01.059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein engineering constitutes a powerful tool for generating novel proteins that serve as catalysts to induce selective chemical and biological transformations that would not otherwise be possible. Protocols that are commonly employed for altering the substrate specificity and selectivity profiles by mutating known enzymes include rational and random methods as well as techniques that entail evolution, selection and screening. Proteins identified by these techniques play important roles in a variety of industrial and medicinal applications and in the study of protein structure-function relationships. Herein we present a critical overview of methods for creating new functional proteins having altered specificity profiles and some practical case studies in which these techniques have been applied to solving problems in synthetic and medicinal chemistry and to elucidating enzyme function and biological pathways. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2701 / 2716
页数:16
相关论文
共 89 条
[1]   Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site [J].
Antikainen, NM ;
Hergenrother, PJ ;
Harris, MM ;
Corbett, W ;
Martin, SF .
BIOCHEMISTRY, 2003, 42 (06) :1603-1610
[2]   A perspective on enzyme catalysis [J].
Benkovic, SJ ;
Hammes-Schiffer, S .
SCIENCE, 2003, 301 (5637) :1196-1202
[3]   De novo design of native proteins: Characterization of proteins intended to fold into antiparallel, rop-like, four-helix bundles [J].
Betz, SF ;
Liebman, PA ;
DeGrado, WF .
BIOCHEMISTRY, 1997, 36 (09) :2450-2458
[4]   Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy [J].
Black, ME ;
Newcomb, TG ;
Wilson, HMP ;
Loeb, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3525-3529
[5]   IDENTIFICATION OF IMPORTANT RESIDUES WITHIN THE PUTATIVE NUCLEOSIDE BINDING-SITE OF HSV-1 THYMIDINE KINASE BY RANDOM SEQUENCE SELECTION - ANALYSIS OF SELECTED MUTANTS IN-VITRO [J].
BLACK, ME ;
LOEB, LA .
BIOCHEMISTRY, 1993, 32 (43) :11618-11626
[6]   De novo design of biocatalysts [J].
Bolon, DN ;
Voigt, CA ;
Mayo, SL .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (02) :125-129
[7]   Improved biocatalysts by directed evolution and rational protein design [J].
Bornscheuer, UT ;
Pohl, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (02) :137-143
[8]  
Braman J, 1996, Methods Mol Biol, V57, P31
[9]   Protein engineering 20 years on [J].
Brannigan, JA ;
Wilkinson, AJ .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :964-970
[10]   Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime [J].
Cantu, C ;
Huang, WZ ;
Palzkill, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22538-22545